Prognostic factors and outcome in patients with T1 high-grade bladder cancer: can we identify patients for early cystectomy?

An analysis of preoperative delays prior to radical cystectomy forbladder cancer in Quebec

(2016) Nader Fahmy et al.   CUAJ-Canadian Urological Association Journal

Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravescal therapy

(2012) Wassim Kassouf et al.   CUAJ-Canadian Urological Association Journal

Association of Intravesical Tumor Location With Metastases to the Pelvic Lymph Nodes in Transitional Cell Cancer of the Bladder

(2010) Steffen Alexander Wedel et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma

(2010) Guido Dalbagni et al.   BJU INTERNATIONAL

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Nonprimary pT1 Nonmuscle Invasive Bladder Cancer Treated With Bacillus Calmette-Guerin is Associated With Higher Risk of Progression Compared to Primary T1 Tumors

(2010) Sultan S. Alkhateeb et al.   JOURNAL OF UROLOGY

Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients

(2009) Mesut Remzi et al.   BJU INTERNATIONAL

Clinical Outcome in a Contemporary Series of Restaged Patients with Clinical T1 Bladder Cancer

(2009) Guido Dalbagni et al.   EUROPEAN UROLOGY

Lymphovascular Invasion and pT Stage Are Prognostic Factors in Patients Treated with Radical Nephroureterectomy for Localized Upper Urinary Tract Transitional Cell Carcinoma

(2009) Dong Suk Kim et al.   UROLOGY